Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-78

StevenJD said it many times.....
IBX will have it's Apple moment., that moment is very close at hand.
Does anyone here know classical music?
I have a feeling multiple means more than 10 patients.
Bob is referring to, now read between the lines here dudes and dudettes.
He says we will have a better indication in Q4 of the likely cadence of recruitment going forward. The sequence of notes or chords comprising the end of the piece.
This says to me momentum is building and now enrolments are happening at a quicker rate.
If you whinge and whine too much you'll miss the big move on IBX and boy is it going to be a huge move up.
The technology works, it's just going to be shown in humans.
At $78 million MC the com is grossly undervalued.
Get set now, don't delay.
As analysts pick up on the enrolments moving forward, there are bound to be quite a few buy recommendations released on IBX.
I think that a number of holders on this site have become too obsessed with the perceived lack of clarity on management's part.
Take a step back, breathe and see what will become one of the ASX most prized biotech companies in many years.
IBX will revolutionise the world of cancer diagnostics and possibly treatment down the track.
There are always delays, we are on the home stretch.
get set and get ready to reap the rewards.